Zhongzhu Medical Financials
| 600568 Stock | 1.48 0.07 4.96% |
Zhongzhu |
Understanding current and past Zhongzhu Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zhongzhu Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Zhongzhu Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Zhongzhu Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zhongzhu Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zhongzhu Medical's management manipulating its earnings.
Specialization | Real Estate, Drug Manufacturers - Specialty & Generic |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE0000017X8 |
| Business Address | Yanlord Binhai Center, |
| Sector | Real Estate Management & Development |
| Industry | Real Estate |
| Benchmark | Dow Jones Industrial |
| Website | www.zz600568.com |
| Phone | 86 72 8640 2068 |
You should never invest in Zhongzhu Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Zhongzhu Stock, because this is throwing your money away. Analyzing the key information contained in Zhongzhu Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Zhongzhu Medical Key Financial Ratios
Zhongzhu Medical's financial ratios allow both analysts and investors to convert raw data from Zhongzhu Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Zhongzhu Medical over time and compare it to other companies across industries.| Return On Equity | -0.0706 | ||||
| Return On Asset | -0.0703 | ||||
| Target Price | 12.5 | ||||
| Beta | 0.34 |
Zhongzhu Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zhongzhu Medical's current stock value. Our valuation model uses many indicators to compare Zhongzhu Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zhongzhu Medical competition to find correlations between indicators driving Zhongzhu Medical's intrinsic value. More Info.Zhongzhu Medical Holdings is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Zhongzhu Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Zhongzhu Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Zhongzhu Medical Holdings Systematic Risk
Zhongzhu Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zhongzhu Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Zhongzhu Medical Holdings correlated with the market. If Beta is less than 0 Zhongzhu Medical generally moves in the opposite direction as compared to the market. If Zhongzhu Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zhongzhu Medical Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zhongzhu Medical is generally in the same direction as the market. If Beta > 1 Zhongzhu Medical moves generally in the same direction as, but more than the movement of the benchmark.
Zhongzhu Medical Thematic Clasifications
Zhongzhu Medical Holdings is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Zhongzhu Medical March 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Zhongzhu Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zhongzhu Medical Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zhongzhu Medical Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Zhongzhu Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zhongzhu Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.05 | |||
| Information Ratio | 0.0838 | |||
| Maximum Drawdown | 7.88 | |||
| Value At Risk | (3.08) | |||
| Potential Upside | 4.8 |
Complementary Tools for Zhongzhu Stock analysis
When running Zhongzhu Medical's price analysis, check to measure Zhongzhu Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhongzhu Medical is operating at the current time. Most of Zhongzhu Medical's value examination focuses on studying past and present price action to predict the probability of Zhongzhu Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhongzhu Medical's price. Additionally, you may evaluate how the addition of Zhongzhu Medical to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |